INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

IMPORTANCE OF THE FIELD: Novel approaches are needed for patients with small cell lung cancer (SCLC), as response after relapse is poor with standard therapies. p53 gene mutations often occur, resulting in tumoral protein overexpression and allowing for their recognition by p53-specific cytotoxic T...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chiappori, Alberto A, Soliman, Hatem, Janssen, William E, Antonia, Scott J, Gabrilovich, Dmitry I
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3146364/
https://ncbi.nlm.nih.gov/pubmed/20420527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2010.484801
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares